- Non-infectious and replication deficient, enables safe handling of positive material
- Fully-extractable with a real viral protein coat; serves as a full-process reference material
- Compatible with assays targeting CDC and WHO consensus sequences
- Includes negative reference material for targeting sequences for the human RNAse P gene
- 2 year stability at 2 - 8°C
- Customisable to sequences of interest to meet unique assay design requirements
-
SeraCare’s SARS-CoV-2 Quality Solution AccuPlex™ SARS-CoV-2 Reference Material, from SeraCare, is designed to measure day-to-day performance of the assay, providing both a positive and a negative reference solution. The product is available in versions that offer different SARS-CoV-2 sequence coverage: Version 1 covers the CDC and WHO consensus sequences, Version 2 has been enhanced to also include the S gene region, and Version 3 is expanded to include the full SARS‐CoV‐2 viral genome (Table 1). All products also include negative reference materials targeting the human RNase P gene. AccuPlex™ SARS-CoV-2 Verification Panel, coupled with the AccuPlex™ SARS-CoV-2 Reference Material, is a complete Quality Solution. Both products are available in three versions with different SARS-CoV-2 sequence coverage: Version 1 covers the CDC and WHO consensus sequences, Version 2 has been enhanced to also include the S gene region, and Version 3 is expanded to include the full SARS-CoV-2 viral genome (Table 1). All products also include negative reference materials targeting the human RNase P gene. -
Clinical Diagnostic Quality Solutions for SARS-CoV-2 Variant Analysis AccuPlex SARS-CoV-2 Variant Panel 1 contains the full SARS-CoV-2 genomic RNA with a focus on S-gene mutations (Table 1) in three prominent variants of concern (VOC): UK variant B.1.1.7, South Africa variant B.1.351, and Brazil variant P.1. The kit has one vial for each variant as well as a fourth wild type (reference sequence NC_045512) control vial. An RNase P negative control vial is also included.- Performance confirmation of existing SARS-CoV-2 molecular assays with different variants
- Reference materials for SARS-CoV-2 variant genotyping assays
- Reference materials for SARS-CoV-2 NGS assays
- Non-infectious and replication deficient, enables safe handling of positive material
- Fully extractable with a real viral protein coat; superior to “naked” transcribed RNA
- 2 year stability at 2 - 8°C
-
Full Genome Coverage now available AccuPlex™ SARS-CoV-2 Verification Panel, from SeraCare, is optimised for assay verification at installation by documenting test performance along the assay’s range enabling laboratories to establish lower limits of detection, perform assay comparisons, and evaluate staff proficiency. The product contains positive materials including the full SARS-CoV-2 viral genome, and negative materials targeting the human RNase P gene. AccuPlex™ SARS-CoV-2 Verification Panel, coupled with the AccuPlex™ SARS-CoV-2 Reference Material, is a complete Quality Solution designed to challenge the entire molecular test procedure ensuring clinical laboratories can have confidence in their SARS-CoV-2 assay results.
- Non-infectious and replication deficient, enables safe handling of positive material
- Fully-extractable with a real viral protein coat; serves as a full-process reference material
- Compatible with assays targeting CDC and WHO consensus sequences
- Includes negative reference material for targeting sequences for the human RNAse P gene
- 2 year stability at 2 - 8°C
- Customisable to sequences of interest to meet unique assay design requirements
-
Measure day-to-day performance AccuPlex™ SARS-CoV-2, Flu A/B and RSV Reference Material Kit, from SeraCare, is designed to measure day-to-day performance of the assay, providing both a positive and a negative reference solution. Designed for use with multiplexed molecular assays that can detect SARS-CoV-2, influenza A/B and respiratory syncytial virus (RSV). AccuPlex™ SARS-CoV-2, Flu A/B and RSV Reference Material Kit, coupled with the AccuPlex™ SARS-CoV-2, Flu A/B and RSV Verification Panel, is a complete Quality Solution designed to challenge the entire molecular test procedure ensuring clinical laboratories can have confidence in their multiplex assay results.
- Non-infectious and replication deficient, enables safe handling of positive material
- Fully-extractable with a real viral protein coat; serves as a full-process reference material
- 2 year stability at 2 - 8°C
- Optimised for assay verification and day-to-day performance monitoring
-
Have confidence in your multiplex assay results for SARS-CoV-2 & Flu A/B AccuPlex™ SARS-CoV-2, Flu A/B and RSV Verification Panel, from SeraCare, is optimised for assay verification at installation by documenting test performance along the assay’s range, enabling laboratories to establish lower limits of detection, perform assay comparisons, and evaluate staff proficiency. Designed for use with multiplexed molecular assays that can detect SARS-CoV-2, influenza A/B and respiratory syncytial virus (RSV). AccuPlex™ SARS-CoV-2, Flu A/B and RSV Verification Panel, coupled with the AccuPlex™ SARS-CoV-2, Flu A/B and RSV Reference Material Kit, is a complete Quality Solution designed to challenge the entire molecular test procedure ensuring clinical laboratories can have confidence in their multiplex assay results.
- Non-infectious and replication deficient, enables safe handling of positive material
- Fully-extractable with a real viral protein coat; serves as a full-process reference material
- 2 year stability at 2 - 8°C
- Optimised for assay verification and day-to-day performance monitoring
-
Ensure antibody testing accuracy and performance To support the many SARS-CoV-2 serology assay formats available, the kit is currently offered in two configurations, one designed for IgG-specific assays and the other for total antibody tests. Series 1000 is released using the Abbott ARCHITECT SARS-CoV-2 IgG assay, and Series 2000 is released using the Roche cobas® Elecsys® Anti-SARS-CoV-2 assay. Reference materials are specifically formulated to exhibit low positive reactivity in true patient-like matrices, to test assay performance near critical signal cutoff boundaries. AccuSet™ SARS-CoV-2 Performance Panel is intended to provide an out-of-the-box solution to evaluate SARS-CoV-2 antibody detection assays with highly characterised human specimens whether generating validation data for a regulatory submission or performing assay verification in a clinical laboratory setting.
-
Ensure antibody testing accuracy and performance AccuSet™ SARS-CoV-2 Performance Panel from SeraCare - This eleven-member validation panel consists of undiluted, naturally occurring human-plasma members. Ten panel members represent collections from multiple individuals positive for antibodies to SARS-CoV-2; a single negative member is also included. Test results from commercially available SARS-CoV-2 antibody assays are included for comparative analysis. AccuSet™ SARS-CoV-2 Performance Panel is intended to provide an out-of-the-box solution to evaluate SARS-CoV-2 antibody detection assays with highly characterized human specimens whether generating validation data for a regulatory submission or performing assay verification in a clinical laboratory setting. ACCURUN® Anti-SARS-CoV-2 Reference Material Kit is designed to support assay installation and monitoring of day-to-day assay performance, providing a complete quality solution for SARS-CoV-2 antibody testing.
-
Real-Time enumeration of individual Bacteria & Somatic Cells in raw milk Semi-Automatic version up to 50 analysis/hour The new BactoCount IBCm 3.0 is a semi-automated instrument that uses a proprietary process based on next-generation flow cytometry for the rapid, highly accurate, reliable and multiplex enumeration of individual bacteria and somatic cells in raw milk. The rapid test for bacteria and somatic cells makes it the ideal solution for any processing plant or laboratory involved in the quality assessment of milk. The instrument offers multiplex applications thanks to its unique dedicated platform. Up to two applications can be run simultaneously on a given sample. The overall design of the instrument has also been designed to allow ease of access and maintenance. With this in mind, IBCm 3.0 embeds a new kinetic, self aligned flow cell mounting system. The BactoCount IBCm 3.0 can be equipped with a conveyor, automating the sampling at a maximum rate of 50 analysis/hour. The sampling, sequencing and identification of the sample vials are functions performed by the Autosampler. Compatible with the ILAS 4000 ROBOT: Automation System for Bacteria Counter -
Why wait? TECHNOPATH partners with CertaBlue for their rapid microbiology technology. CertaBlue is based on rapid detection of several metabolic processes that take place within the growing organism. The system can detect colour changes through highly sensitive optical sensors. All vials are ready to use, prefilled with media and equipped with CertaBlue sensors. In most cases, the vials can be inoculated with a non-diluted high volume sample. The CertaBlue vials contain an optical sensor, which can detect carbon dioxide as the universal indicator for microbial growth. The sensor is placed in the bottom of the vial, where it directly detects carbon dioxide changes. CertaBlue sensors are only permeable for gases. Liquids, dyed / heavily coloured products and other particles can’t falsify results. What can CertaBlue offer you:- Simplified test procedures
- Ready-to-use vials including media and CertaBlue sensor
- Test procedure consists of just adding your sample to the vial
- Results in hours instead of days
- Real-time detection and early warning of positive samples
- Ensures a quick and safe product release
- Better recovery of injured and / or damaged microorganisms
-
Hands-on training & performance verification improves pathogen detection. Data collected from environmental sampling of surfaces is highly dependent on the operator. Understanding and quantitatively characterising the percent recovery and consistency of sample collection by an operator drives improved detection and prevention of pathogens. Performance verification involves determining the percent recovery and consistency of an operator who collects samples in an environmental sampling program. Introducing Enverify™, a quantitative positive control for environmental sampling programs and comprises a flat substrate with a specific quantity of viable microorganisms coated on the surface. The microbes are safe-to-handle and are coated across a 10 cm x 10 cm area. Enverify™ provides a standardised tool for hands-on training and performance verification of operators that collect samples in environmental sampling programs. Enverify™ is compatible with contact plates, swab sampling devices, and sponge sample devices. Activities Involving Environmental Sampling:- Environmental monitoring for pathogens or indicator organisms
- Sanitation verification using ATP or indicator organisms
- Verification of hygienic restoration following adverse events
- Verification of containment during construction activities
-
Microbial-coated test surfaces for evaluating surface sampling competency Qualification of personnel who collect surface samples is a regulatory requirement and a crucial activity for an effective environmental monitoring program. Personnel sampling performance, including percent recovery, consistency, and aseptic technique, drives the quality of data that is generated and significantly impacts the integrity of an environmental monitoring program. Introducing Enverify™, the industry standard for evaluating surface sampling competency. Enverify™ Test Surfaces, from Stratix Labs, are the first standardised tool that enables you to evaluate and document surface sampling competency with quantitative data. Each Enverify™ Test Surface contains a precise quantity of microorganisms, providing a benchmark for you to evaluate, verify, and compare performance. Enverify™ is designed for use with contact plates and swab sampling tools. -
Solid Phase Cytometry meets Artificial Intelligence TECHNOPATH partners with Microbs for their fully automated solution. To boost productivity in your microbial QC lab, Microbs launches IAN®, an Ultra Rapid Microbiological Method allowing an accurate enumeration of bacteria, yeast and mould within minutes, not days! With IAN®, you can redesign your quality control. No need to wait days to check the microbiological quality of your production. IAN® gives you a quantitative measurement of your contamination in 15 minutes using our innovative direct non-growth detection method.- Mobile Laboratory - Autonomous, its fits where you need it.
- Speed - Time to result: 15 minutes, no enrichment needed.
- Simplicity - No expertise required
- Accuracy - Detection range from 1 to ≈ 5 000 microorganisms/volume analysed
- Liquid sample - Sampling from 100µL to 200mL
- Traceability - Full Data integrity, 21 CFR 11 compliant